Neuroone Medical Technologies Corp
NASDAQ:NMTC

Watchlist Manager
Neuroone Medical Technologies Corp Logo
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Watchlist
Price: 0.705 USD -0.28%
Market Cap: 35.3m USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Neuroone Medical Technologies Corp

Revenue
9.6m USD
Cost of Revenue
-2.9m USD
Gross Profit
6.8m USD
Operating Expenses
-12.4m USD
Operating Income
-5.7m USD
Other Expenses
335.4k USD
Net Income
-5.3m USD

Margins Comparison
Neuroone Medical Technologies Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Neuroone Medical Technologies Corp
NASDAQ:NMTC
35.2m USD
70%
-59%
-55%
US
Abbott Laboratories
NYSE:ABT
219.6B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
206.8B USD
66%
29%
29%
US
Boston Scientific Corp
NYSE:BSX
149.6B USD
69%
19%
14%
US
Stryker Corp
NYSE:SYK
135.9B USD
65%
22%
12%
IE
Medtronic PLC
NYSE:MDT
121B USD
65%
20%
14%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
62%
31%
25%
DE
Siemens Healthineers AG
XETRA:SHL
49.1B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
52.1B USD
45%
14%
8%
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
78%
28%
23%
US
Resmed Inc
NYSE:RMD
36.5B USD
60%
33%
27%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Neuroone Medical Technologies Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Neuroone Medical Technologies Corp
NASDAQ:NMTC
35.2m USD
-95%
-68%
-90%
-234%
US
Abbott Laboratories
NYSE:ABT
219.6B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
206.8B USD
17%
15%
17%
22%
US
Boston Scientific Corp
NYSE:BSX
149.6B USD
13%
7%
11%
9%
US
Stryker Corp
NYSE:SYK
135.9B USD
14%
6%
14%
12%
IE
Medtronic PLC
NYSE:MDT
121B USD
10%
5%
8%
7%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
65%
31%
58%
35%
DE
Siemens Healthineers AG
XETRA:SHL
49.1B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
52.1B USD
7%
3%
6%
5%
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD
14%
10%
14%
16%
US
Resmed Inc
NYSE:RMD
36.5B USD
25%
19%
26%
22%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less